BLRX

BioLineRX

26 hedge funds and large institutions have $13.9M invested in BioLineRX in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 7 closing their positions.

Holders
26
Holders Change
-7
Holders Change %
-21.21%
% of All Funds
0.57%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
4
Reduced
2
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
BI
1
BVF Inc
California
$9.49M 25,995,575
SM
2
Senvest Management
New York
$2.75M 7,538,845
Morgan Stanley
3
Morgan Stanley
New York
$519K 1,421,862 +477,798 +51%
O
4
OrbiMed
New York
$379K 1,038,600
FI
5
Fosun International
China
$263K 730,228
DG
6
Delek Group
Israel
$134K 375,047 +159,469 +74%
OM
7
Opaleye Management
Massachusetts
$91K 250,000
SAM
8
Sectoral Asset Management
Quebec, Canada
$65K 178,297
Geode Capital Management
9
Geode Capital Management
Massachusetts
$31K 86,595 +28,967 +50%
NFG
10
Next Financial Group
Texas
$27K 73,000 +33,000 +83%
CCB
11
Cutter & Co Brokerage
Missouri
$21K 57,000
VanEck Associates
12
VanEck Associates
New York
$20K 55,215 -3,732 -6%
Wells Fargo
13
Wells Fargo
California
$15K 40,530
MCC
14
Malaga Cove Capital
California
$9K 24,000
Commonwealth Equity Services
15
Commonwealth Equity Services
Massachusetts
$8K 22,330
DBRC
16
D.B. Root & Company
Pennsylvania
$7K 20,000
RhumbLine Advisers
17
RhumbLine Advisers
Massachusetts
$5K 12,712
LPL Financial
18
LPL Financial
California
$5K 13,000
Creative Planning
19
Creative Planning
Kansas
$4K 10,000
CAN
20
Cetera Advisor Networks
California
$4K 10,000
FWM
21
Focused Wealth Management
New York
$2K 5,000
LTFS
22
Ladenburg Thalmann Financial Services
Florida
$1K 2,000 -275 -12%
Royal Bank of Canada
23
Royal Bank of Canada
Ontario, Canada
$1K 3,000
DWM
24
Doyle Wealth Management
Florida
$1K 3,060 +3,060 New
RE
25
RBC Europe
United Kingdom
$73 200